If you have any further queries, please contact CPNI. I look forward to seeing you on Tuesday evening.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please see attached correspondence in relation to a grant funding allocation relating to DM+D clinical system amendment.
ACTION
Contractors are advised to:
Note the correspondence from SPPG Pharmacy & Medicines Management team; and
Complete the form at Appendix A and return it to your local SPPG Primary Care Office by Friday 25th November 2022.
Please contact a member of the CPNI team should you have any queries.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
SECURING PERSONAL AND BUSINESS EMAILS AND MEDIA ACCOUNTS
As part of Cyber Security month, the PSNI Cyber Crime Centre and partners have been raising awareness of the steps that can be taken to secure personal email and social media accounts from being ‘hacked’.
As the most reported cyber-dependent crime by individuals in NI and the UK as a whole, the ‘hacking’ or compromise of an email or social media account can lead to the loss of personal information, images and potentially lead to the targeting or friends, family or work colleagues by an attacker using your account.
The attached document issued by the PSNI Cyber Crime Centre offers advice on securing your accounts.
ACTION
Contractors are advised to:
Read the attached information sheet and to take the appropriate actions to secure any relevant personal and business accounts; and
Raise staff awareness as to the importance of cyber security.
Further information can be accessed via the New Cyber Protect webpage HERE.
Kind regards – Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY Head of Regulatory Affairs
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
The final update of concessionary prices were granted today for October 2022:
Drug
Pack Size
Concessionary Price
Aripiprazole 1mg/ml oral solution
150
£104.90
Bumetanide 1mg/5ml oral solution sugar free
150
£235.00
Chlorphenamine 2mg/5ml oral solution
150
£4.09
Chlorphenamine 2mg/5ml oral solution sugar free
150
£2.80
Cilostazol 100mg tablets
56
£14.99
Clobazam 10mg/5ml oral suspension sugar free
56
£90.28
Clobazam 10mg/5ml oral suspension sugar free
250
£150.46
Co-amilofruse 2.5mg/20mg tablets
28
£3.90
Docusate 50mg/5ml oral solution sugar free
300
£20.25
Doxycycline 100mg capsules
8
£0.85
Fluoxetine 40mg capsules
30
£2.47
Hydralazine 25mg tablets
56
£4.57
Ivabradine 5mg tablets
56
£6.70
Liothyronine 5microgram tablets
28
£100.94
Methotrexate 2.5mg tablets
28
£1.68
Mometasone 0.1% cream
100
£9.48
Nadolol 80mg tablets
28
£9.00
Nebivolol 10mg tablets
28
£28.18
Rabeprazole 20mg gastro-resistant tablets
28
£11.84
Rivastigmine 3mg capsules
28
£4.75
Yellow soft paraffin solid
500
£5.65
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE
Chief Executive
Dear Colleague
The fifth update of concessionary prices were granted today for October 2022:
Drug
Pack Size
Concessionary Price
Aripiprazole 15mg tablets
28
£36.80
Aripiprazole 5mg tablets
28
£37.78
Carbocisteine 375mg capsules
120
£17.04
Chloramphenicol 1% eye ointment
4
£3.38
Citalopram 20mg tablets
28
£1.96
Clindamycin 150mg capsules
24
£4.42
Codeine 30mg tablets
100
£3.96
Codeine 30mg tablets
28
£1.11
Co-trimoxazole 80mg/400mg tablets
28
£5.15
Digoxin 125microgram tablets
28
£1.53
Digoxin 62.5microgram tablets
28
£3.83
Gabapentin 300mg capsules
100
£3.33
Ibandronic acid 150mg tablets
1
£1.80
Levetiracetam 100mg/ml oral solutionsugar free
300
£9.15
Mometasone 0.1% cream
30
£4.32
Mometasone 0.1% ointment
30
£4.19
Mometasone 50micrograms/dose nasal spray
140
£3.71
Pregabalin 75mg capsules
56
£1.83
Quinine sulfate 200mg tablets
28
£3.97
Risperidone 500microgram tablets
20
£3.55
Temazepam 20mg tablets
28
£29.95
Tetracycline 250mg tablets
28
£14.39
Venlafaxine 37.5mg tablets
56
£3.53
Venlafaxine 75mg tablets
56
£16.14
Zolmitriptan 2.5mg tablets
12
£22.01
Zolmitriptan 2.5mg tablets
6
£11.01
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF GERARD GREENE
Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.